Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Collegium Pharmaceutical Inc..
Collegium Pharmaceutical Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Collegium Pharmaceutical Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Collegium Pharmaceutical Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Collegium Pharmaceutical Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Collegium Pharmaceutical Inc. and all latest updates of the company are provided.
The 2025 version of Collegium Pharmaceutical Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Collegium Pharmaceutical Inc.- Key Facts
2.2 Collegium Pharmaceutical Inc.- Geographic Locations
2.3 Collegium Pharmaceutical Inc.- Subsidiaries and Affiliates
2.4 Collegium Pharmaceutical Inc.- Business Divisions
2.5 Collegium Pharmaceutical Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Collegium Pharmaceutical Inc. Strategic Analysis Review
3.1 Collegium Pharmaceutical Inc.- Key Strategies
3.2 Collegium Pharmaceutical Inc.- Company Outlook Statement
3.3 Collegium Pharmaceutical Inc.- SWOT Analysis
3.3.1 Collegium Pharmaceutical Inc.- Key Strengths
3.3.2 Collegium Pharmaceutical Inc.- Key Weaknesses
3.3.3 Collegium Pharmaceutical Inc.- Potential Opportunities
3.3.4 Collegium Pharmaceutical Inc.- Potential Threats
3.4 Collegium Pharmaceutical Inc.- Key Competitors
4. Business Description of the Company
4.1 Collegium Pharmaceutical Inc.- Business Overview
4.2 Collegium Pharmaceutical Inc.- Operations by Segment
5 Products and Services Details
5.1 Collegium Pharmaceutical Inc.- Key Products
5.2 Collegium Pharmaceutical Inc.- Key Service Areas
5.3 Collegium Pharmaceutical Inc.- Key Brands
6 Company Developments
6.1 Collegium Pharmaceutical Inc.- Company History
6.2 Collegium Pharmaceutical Inc.- Latest Developments
7 Financial Analysis
7.1 Collegium Pharmaceutical Inc.- Income Statements
7.2 Collegium Pharmaceutical Inc.- Balance Sheet
7.3 Collegium Pharmaceutical Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Collegium Pharmaceutical Inc.- Direct Competitors
8.2 Collegium Pharmaceutical Inc.- Competitor Financial Ratios comparison
8.3 Collegium Pharmaceutical Inc.- Competitor Stock Charts Comparison
8.4 Collegium Pharmaceutical Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!